Article

Endocarditis: Infection, Antiphospholipid Syndrome, or Something Else?

For a patient who presented with symptoms of stroke, the initial diagnosis (antiphospholipid syndrome) proved secondary to the actual cause of endocarditis.

Wangemail LW, Noël B, Descloux E, Baron DW. Antiphospholipid syndrome: an important differential diagnosis for culture-negative endocarditis.The American Journal of Medicine. 2014 Accepted manuscript. doi: http://dx.doi.org/10.1016/j.amjmed.2014.11.010

This case study discusses a 37-year-old woman suspected of having cardioembolic stroke, based on results of transesophageal echocardiography, after she presents with sudden-onset persistent left-sided weakness.

Her poor dentition raises a suspicion of infective endocarditis. However, serology and blood cultures are negative for microorganisms.

Procoagulant screening identifies lupus anticoagulant, anticardiolipin IgG antibodies, and anti-β2 glycoprotein I IgG antibodies. The vasculitic screen reveals a positive antinuclear antibody titer, but is negative for a number of antibodies and antigens. 

The physicians render a tentative diagnosis of nonbacterial thrombotic endocarditis due to antiphospholipid syndrome, pending interval testing 12 weeks later.

A vasculitic screen 4 months after the initial presentation confirms the diagnosis of nonbacterial thrombotic endocarditis. She is started on hydroxychloroquine.

After deterioration of her renal function, kidney biopsy shows mild mesangioproliferative changes with focal segmental sclerosis.

This fulfills 4 of 11 criteria for systemic lupus enrytematosus: positive antinuclear antibodies, hematological abnormalities, renal abnormalities, and positive antiphospholipid antibodies.

The authors point out the need to be aware that the initial diagnosis may actually be secondary to the actual causative condition.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.